SWISS-MODEL: homology modelling of protein structures and complexes
Retatrutide is predicted at $1,200-1,500/month compared to Zepbound's $1,060
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F et al
Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS) studies have shown that tirzepatide reduced HbA1c and fasting glucose levels more than the titrated insulin degludec, insulin glargine or 1 mg once a week semaglutide independently of the baseline levels of HbA1c
Active ingredients For a portion
Treat the preparation as single-use unless the IMP label explicitly states it is a multi-dose preparation containing a preservative and specifies conditions for reuse